_id
6914877bccc777a4e85d9707
Ticker
OKUR
Name
OnKure Therapeutics, Inc.
Exchange
NASDAQ
Address
6707 Winchester Circle, Boulder, CO, United States, 80301
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://onkuretherapeutics.com
Description
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3 kinase alpha harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company is headquartered in Boulder, Colorado.
Last Close
2.94
Volume
19323
Current Price
3.21
Change
0.06
Last Updated
2026-01-05T12:06:36.695Z
Image
data:image/webp;base64,UklGRk4BAABXRUJQVlA4IEIBAADwBwCdASpAAEAAPtFYpU2oJKMiLBqpmQAaCUAZDrQFuA3is7KuwLgJ15tSTEtMWawjZ7BQTx8T6zcy7V83SWNZl017FXVAUQAA/vaAOUK3PSIbBRIWN2k0OhrJL1eUF7ov81C28ULJJl1iNtJZ1otelmDaT4wpDpbI1+O2vLuxPrskZAbktoIL7GPArrgzehUbHz88buqOTZx4h6iO4UFSVQU+e2lBAesbQvs+o7Mx6KBM8RoZdmy0neIQWfyPaIxZ5XpnSGp2RuHSjh+ZPlWtmxwYxJGQRo3iPOscl7N31DVg5t5moc0Iqx7Xq6RVqTXRlE9WQR1QDciCfN7TJ/4fGDcDBZk6sq9zdHwAtmi3FKKJ/ZvE61nBd5uZ2qNywIPJfrWVT2v5yBbiO+NvEqg+zjni0UUt7lf0jE1IEL3pUAAA
Ipo Date
2024-10-07T00:00:00.000Z
Market Cap
40102672
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.8333
Target Price
27
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
15501000
Operating Income
-15501000
Interest Expense
2000
Pretax Income
-14699000
Net Income
-14699000
Eps
-1.0880829782635086
Dividends Per Share
-
Shares Outstanding
12861672
Income Tax Expense
-
EBITDA
-14493000
Operating Margin
-
Total Other Income Expense Net
802000
Cash
70331000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
71526000
Property Plant Equipment
1205000
Total Assets
72835000
Payables
1290000
Short Term Debt
567000
Long Term Debt
-
Total Liabilities
6407000
Equity
66428000
Bs_currency_symbol
USD
Depreciation
204000
Change In Working Capital
-1505000
Cash From Operations
-13037000
Capital Expenditures
6000
Cash From Investing
-6000
Cash From Financing
0
Net Change In Cash
-13043000
Cf_currency_symbol
USD
PE
-
PB
0.6527992232191244
ROE
-22.127717227675074
ROA
-20.18123155076543
FCF
-13043000
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
6
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
7
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
15501000
Quarters > 0 > income Statement > operating Income
-15501000
Quarters > 0 > income Statement > interest Expense
2000
Quarters > 0 > income Statement > pretax Income
-14699000
Quarters > 0 > income Statement > net Income
-14699000
Quarters > 0 > income Statement > eps
-1.0880829782635086
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
13509080
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-14493000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
802000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
70331000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
71526000
Quarters > 0 > balance Sheet > property Plant Equipment
1205000
Quarters > 0 > balance Sheet > total Assets
72835000
Quarters > 0 > balance Sheet > payables
1290000
Quarters > 0 > balance Sheet > short Term Debt
567000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
6407000
Quarters > 0 > balance Sheet > equity
66428000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-14699000
Quarters > 0 > cash Flow > depreciation
204000
Quarters > 0 > cash Flow > change In Working Capital
-1505000
Quarters > 0 > cash Flow > cash From Operations
-13037000
Quarters > 0 > cash Flow > capital Expenditures
6000
Quarters > 0 > cash Flow > cash From Investing
-6000
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-13043000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-1.0880829782635086
Quarters > 0 > ratios > PB
0.6527992232191244
Quarters > 0 > ratios > ROE
-22.127717227675074
Quarters > 0 > ratios > ROA
-20.18123155076543
Quarters > 0 > ratios > FCF
-13043000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
212000
Quarters > 1 > income Statement > gross Profit
-212000
Quarters > 1 > income Statement > operating Expenses
16324000
Quarters > 1 > income Statement > operating Income
-16324000
Quarters > 1 > income Statement > interest Expense
0
Quarters > 1 > income Statement > pretax Income
-15390000
Quarters > 1 > income Statement > net Income
-15390000
Quarters > 1 > income Statement > eps
-1.139233759811919
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
13509080
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-15178000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
934000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
83374000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
84552000
Quarters > 1 > balance Sheet > property Plant Equipment
1402000
Quarters > 1 > balance Sheet > total Assets
86070000
Quarters > 1 > balance Sheet > payables
2381000
Quarters > 1 > balance Sheet > short Term Debt
556000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
7904000
Quarters > 1 > balance Sheet > equity
78166000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-15390000
Quarters > 1 > cash Flow > depreciation
212000
Quarters > 1 > cash Flow > change In Working Capital
-1004000
Quarters > 1 > cash Flow > cash From Operations
-13274000
Quarters > 1 > cash Flow > capital Expenditures
13000
Quarters > 1 > cash Flow > cash From Investing
-13000
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-13287000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.139233759811919
Quarters > 1 > ratios > PB
0.5547699357777038
Quarters > 1 > ratios > ROE
-19.688867282450172
Quarters > 1 > ratios > ROA
-17.880794701986755
Quarters > 1 > ratios > FCF
-13287000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
212000
Quarters > 2 > income Statement > gross Profit
-212000
Quarters > 2 > income Statement > operating Expenses
17000000
Quarters > 2 > income Statement > operating Income
-17000000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-15925000
Quarters > 2 > income Statement > net Income
-15925000
Quarters > 2 > income Statement > eps
-1.1862785009462293
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
13424335
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-16788000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1075000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
96661000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
98172000
Quarters > 2 > balance Sheet > property Plant Equipment
1601000
Quarters > 2 > balance Sheet > total Assets
99882000
Quarters > 2 > balance Sheet > payables
2344000
Quarters > 2 > balance Sheet > short Term Debt
546000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
9234000
Quarters > 2 > balance Sheet > equity
90648000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-15925000
Quarters > 2 > cash Flow > depreciation
212000
Quarters > 2 > cash Flow > change In Working Capital
-1037000
Quarters > 2 > cash Flow > cash From Operations
-14005000
Quarters > 2 > cash Flow > capital Expenditures
18000
Quarters > 2 > cash Flow > cash From Investing
-18000
Quarters > 2 > cash Flow > cash From Financing
-77000
Quarters > 2 > cash Flow > net Change In Cash
-14100000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-1.1862785009462293
Quarters > 2 > ratios > PB
0.475378556063013
Quarters > 2 > ratios > ROE
-17.567955167240314
Quarters > 2 > ratios > ROA
-15.943813700166196
Quarters > 2 > ratios > FCF
-14023000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
419000
Quarters > 3 > income Statement > gross Profit
-419000
Quarters > 3 > income Statement > operating Expenses
33795000
Quarters > 3 > income Statement > operating Income
-33795000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-35194000
Quarters > 3 > income Statement > net Income
-35194000
Quarters > 3 > income Statement > eps
-2.6383461885928
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
13339417
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-31160000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-1399000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
110761000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
113003000
Quarters > 3 > balance Sheet > property Plant Equipment
1795000
Quarters > 3 > balance Sheet > total Assets
114907000
Quarters > 3 > balance Sheet > payables
2968000
Quarters > 3 > balance Sheet > short Term Debt
536000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
11079000
Quarters > 3 > balance Sheet > equity
103828000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-35194000
Quarters > 3 > cash Flow > depreciation
622000
Quarters > 3 > cash Flow > change In Working Capital
9858000
Quarters > 3 > cash Flow > cash From Operations
-21015000
Quarters > 3 > cash Flow > capital Expenditures
50000
Quarters > 3 > cash Flow > cash From Investing
-45375000
Quarters > 3 > cash Flow > cash From Financing
114218000
Quarters > 3 > cash Flow > net Change In Cash
50072000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-2.6383461885928
Quarters > 3 > ratios > PB
0.41240829612435953
Quarters > 3 > ratios > ROE
-33.89644411912008
Quarters > 3 > ratios > ROA
-30.628247191206803
Quarters > 3 > ratios > FCF
-21065000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
662000
Annuals > 0 > income Statement > gross Profit
-662000
Annuals > 0 > income Statement > operating Expenses
54386000
Annuals > 0 > income Statement > operating Income
-54386000
Annuals > 0 > income Statement > interest Expense
300000
Annuals > 0 > income Statement > pretax Income
-52673000
Annuals > 0 > income Statement > net Income
-52673000
Annuals > 0 > income Statement > eps
-3.9486733190813363
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
13339417
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-51711000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
1713000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
110761000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
113003000
Annuals > 0 > balance Sheet > property Plant Equipment
1795000
Annuals > 0 > balance Sheet > total Assets
114907000
Annuals > 0 > balance Sheet > payables
2968000
Annuals > 0 > balance Sheet > short Term Debt
536000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
11079000
Annuals > 0 > balance Sheet > equity
103828000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-52673000
Annuals > 0 > cash Flow > depreciation
662000
Annuals > 0 > cash Flow > change In Working Capital
-3952000
Annuals > 0 > cash Flow > cash From Operations
-51117000
Annuals > 0 > cash Flow > capital Expenditures
52000
Annuals > 0 > cash Flow > cash From Investing
15873000
Annuals > 0 > cash Flow > cash From Financing
116129000
Annuals > 0 > cash Flow > net Change In Cash
80885000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-3.9486733190813363
Annuals > 0 > ratios > PB
0.3802892699464499
Annuals > 0 > ratios > ROE
-50.73101668143468
Annuals > 0 > ratios > ROA
-45.839679044792746
Annuals > 0 > ratios > FCF
-51169000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
560000
Annuals > 1 > income Statement > gross Profit
-560000
Annuals > 1 > income Statement > operating Expenses
36934000
Annuals > 1 > income Statement > operating Income
-36934000
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-35311000
Annuals > 1 > income Statement > net Income
-35311000
Annuals > 1 > income Statement > eps
-2.6471171866056813
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
13339417
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-34751000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
1623000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
29876000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
33766000
Annuals > 1 > balance Sheet > property Plant Equipment
1910000
Annuals > 1 > balance Sheet > total Assets
35734000
Annuals > 1 > balance Sheet > payables
3417000
Annuals > 1 > balance Sheet > short Term Debt
208000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
137576000
Annuals > 1 > balance Sheet > equity
-101842000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-35311000
Annuals > 1 > cash Flow > depreciation
560000
Annuals > 1 > cash Flow > change In Working Capital
6000
Annuals > 1 > cash Flow > cash From Operations
-34546000
Annuals > 1 > cash Flow > capital Expenditures
246000
Annuals > 1 > cash Flow > cash From Investing
-246000
Annuals > 1 > cash Flow > cash From Financing
53125000
Annuals > 1 > cash Flow > net Change In Cash
18333000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-2.6471171866056813
Annuals > 1 > ratios > PB
-0.38770521317334694
Annuals > 1 > ratios > ROE
34.67233557864142
Annuals > 1 > ratios > ROA
-98.81625342810769
Annuals > 1 > ratios > FCF
-34792000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
529000
Annuals > 2 > income Statement > gross Profit
-529000
Annuals > 2 > income Statement > operating Expenses
29766000
Annuals > 2 > income Statement > operating Income
-29766000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-29512000
Annuals > 2 > income Statement > net Income
-29512000
Annuals > 2 > income Statement > eps
-2.2123905415056746
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
13339417
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-29379000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
254000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
11543000
Annuals > 2 > balance Sheet > short Term Investments
81246000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
13623000
Annuals > 2 > balance Sheet > property Plant Equipment
2047000
Annuals > 2 > balance Sheet > total Assets
15999000
Annuals > 2 > balance Sheet > payables
2520000
Annuals > 2 > balance Sheet > short Term Debt
151000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
70417000
Annuals > 2 > balance Sheet > equity
-54418000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-29512000
Annuals > 2 > cash Flow > depreciation
387000
Annuals > 2 > cash Flow > change In Working Capital
2124000
Annuals > 2 > cash Flow > cash From Operations
-26953000
Annuals > 2 > cash Flow > capital Expenditures
1134000
Annuals > 2 > cash Flow > cash From Investing
-1134000
Annuals > 2 > cash Flow > cash From Financing
26465000
Annuals > 2 > cash Flow > net Change In Cash
-1622000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-2.2123905415056746
Annuals > 2 > ratios > PB
-0.7255811371237458
Annuals > 2 > ratios > ROE
54.232055569848214
Annuals > 2 > ratios > ROA
-184.46152884555283
Annuals > 2 > ratios > FCF
-28087000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
50000
Annuals > 3 > income Statement > gross Profit
-50000
Annuals > 3 > income Statement > operating Expenses
39768000
Annuals > 3 > income Statement > operating Income
-39818000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-39770000
Annuals > 3 > income Statement > net Income
-39770000
Annuals > 3 > income Statement > eps
-21.91971992142632
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1814348
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-39720000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
48000
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
124660000
Annuals > 3 > balance Sheet > short Term Investments
23010000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
153734000
Annuals > 3 > balance Sheet > property Plant Equipment
212000
Annuals > 3 > balance Sheet > total Assets
154024000
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
6813000
Annuals > 3 > balance Sheet > equity
147211000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-39770000
Annuals > 3 > cash Flow > depreciation
50000
Annuals > 3 > cash Flow > change In Working Capital
-2800000
Annuals > 3 > cash Flow > cash From Operations
-37983000
Annuals > 3 > cash Flow > capital Expenditures
198000
Annuals > 3 > cash Flow > cash From Investing
-23376000
Annuals > 3 > cash Flow > cash From Financing
132406000
Annuals > 3 > cash Flow > net Change In Cash
71047000
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-21.91971992142632
Annuals > 3 > ratios > PB
0.03648144554415091
Annuals > 3 > ratios > ROE
-27.015644211370077
Annuals > 3 > ratios > ROA
-25.820651327065914
Annuals > 3 > ratios > FCF
-38181000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
41
Valuation > metrics > PE
-1.0880829782635086
Valuation > metrics > PB
0.6527992232191244
Valuation > final Score
70
Valuation > verdict
34.7% Undervalued
Profitability > metrics > ROE
-22.127717227675074
Profitability > metrics > ROA
-20.550569023851466
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.09645029204552297
Risk > metrics > Interest Coverage
-7750.5
Risk > final Score
-30942
Risk > verdict
High
Liquidity > metrics > Current Ratio
38.51696284329564
Liquidity > metrics > Quick Ratio
38.51696284329564
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-248
Prev Risks > 1
-19
Prev Risks > 2
26
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:20:32.388Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-07
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-1.09
Earnings History > 0 > eps Estimate
-1.198
Earnings History > 0 > eps Difference
0.108
Earnings History > 0 > surprise Percent
9.015
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-13
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.14
Earnings History > 1 > eps Estimate
-1.248
Earnings History > 1 > eps Difference
0.108
Earnings History > 1 > surprise Percent
8.6538
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-05
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-1.1863
Earnings History > 2 > eps Estimate
-1.38
Earnings History > 2 > eps Difference
0.1937
Earnings History > 2 > surprise Percent
14.0362
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-11
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-1.37
Earnings History > 3 > eps Estimate
-0.87
Earnings History > 3 > eps Difference
-0.5
Earnings History > 3 > surprise Percent
-57.4713
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-06
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.86
Earnings History > 4 > eps Estimate
-0.9
Earnings History > 4 > eps Difference
0.04
Earnings History > 4 > surprise Percent
4.4444
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-13
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-1.6041
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-07
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-2.5212
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-28
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-7.0477
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-5.678
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-6.4639
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-6.034
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-27
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-5.5368
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-08
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-5.3098
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-09
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-5.0327
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-11
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-5.3299
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-24
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-4.3373
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-12
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-5.2199
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-11
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-4.3137
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-20
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-2.9696
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3 kinase alpha harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company is headquartered in Boulder, Colorado.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AUS Market Wrap: Will Loews Corporation stock go up in YEAR - Quarterly Market Review & High Win Rate Trade Alerts baoquankhu1.vn
Read more →Analyzing Nautilus Biotechnology (NASDAQ:NAUT) and OnKure Therapeutics (NASDAQ:OKUR) - Defense World
1/19/2026
Analyzing Nautilus Biotechnology (NASDAQ:NAUT) and OnKure Therapeutics (NASDAQ:OKUR) Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$27
Analyst Picks
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of OnKure Therapeutics, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-1.09
EPS Estimate
-1.198
EPS Difference
0.108
Surprise Percent
9.015%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.